CinRx is a Biotech Portfolio Company founded in 2015 that leverages its team’s exceptional industry experience to develop therapeutics in a novel way that meets the modern paradigm of drug development. CinRx acquires compounds from multiple sources, as well as partners with other biotechnology companies, to invest in and develop innovative products that will transform the lives of patients. With its broad preclinical, clinical pharmacology, medical, biostatistical and regulatory expertise, CinRx accelerates drug development programs to help achieve marketing approval or bring about a successful commercial exit.
Location: United States, Ohio, Cincinnati
Employees: 11-50
Total raised: $83M
Founded date: 2015
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.06.2024 | - | $73M | - |
| 28.11.2017 | Series B | $10M | - |
Mentions in press and media 4
| Date | Title | Description |
| 02.06.2024 | CinRx Pharma Closes Additional $73M Financing | CinRx Pharma, a Cincinnati, OH-based hub-and-spoke biotech company, raised additional $73M in funding. The round, which brought the total amount to $176M, included participation from industry insiders and individuals. The company intends to... |
| 16.08.2018 | 14 Health-Related Companies That Have Raised More Than $100K | It’s not exactly a secret that Queen City is the home to a host of startups. While there are certain trends among those represented in greater Cincinnati — such as, say, branding or consumer good — various industries have found success in t... |
| 28.11.2017 | CinRx Closes $10M Series B Financing Round | CinRx, a North Industrial Zone Lod, Israel- and Cincinnati, OH-based biopharmaceutical company developing novel therapeutics that address diverse therapeutic areas, completed its $10m Series B round of financing. Backers included both curre... |
| - | CinRx Pharma | - |